Assessment of a neuroendocrine tumour by 111In-pentetreotid scintigraphy and PET with 18F-FDOPA and 18F-FDG;Valoración de un tumor neuroendocrino mediante gammagrafía con 111In-pentetreótido y PET con 18F-FDOPA y 18F-FDG

Revista Espanola de Medicina Nuclear

Volumn 23, Issue 6, 2004, Pages 421-424

  Plaza, P ^a   Montravers, F ^b   Aide, N ^b   Carrera, D ^a   Kerrou, K ^b   Ferran, N ^a   Grahek, D ^b   Talbot, J N ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HÔPITAL TENON   (France)

Author keywords

In111 pentetreotide; Neuroendocrine tumors; PET FDG; PET FDOPA

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PENTETREOTIDE IN 111;

ADRENAL HYPERPLASIA; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; MEDICAL ASSESSMENT; NEUROENDOCRINE TUMOR; PROGNOSIS; SMALL INTESTINE TUMOR;

EID: 10644283923     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067829     Document Type: Article

References (8)

1. Belhocine T, Foidart J, Rigo P, et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing carcinoid tumours: correlations with pathological indexes p53 and Ki-67. Nucl Med Commun 2002;23:727-34.
2. Dimitrakopoulou-Strauss A, Strauss L G, and Burger Cyrill. Quantitative PET studies in pretreated melanoma patients: A comparison of 6-[18F]Fluoro-L-Dopa with 18F-FDG and 150-Water using compartment and noncompartment analysis. J Nucl Med 2001;42:248-56.
3. Banzo J, Abos M D, et al. Gammagrafia de receptores de somatostatina. ¿Cuándo hacer una SPECT?. Rev Esp Med Nuclear 2002; 22:68-75.
4. Hoegerle S, Altehoefer C, et al. Whole-body 18F Dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220:373-80.
5. Jacob T, Grahek D, et al. La TEP à la 18F-PDOPA dans l'imagerie des carcinomes bronchiques à petites cellules: comparaison avec l'imagerie conventionnelle et la TEP au 18F-FDG. Résultats préliminaires. Médecine nucléaire 2003;27:353-7.
6. Montravers F, Younsi N, et al. 18F-DOPA-PET for tumor detection in patients with neuroendocrine digestive tumors: preliminary results. Eur J Nucl Med 2003;30:203.
7. Pacak K, Eisennhofer G, et al. 6-18F-Fluorodopamine positron emission tomographic PET scanning for diagnostic localization of pheochromocitoma. Hypertension 2001;38:6-8.
8. Hoegerle S, Altehoefer C, et al. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonim levels. Eur J Nucl Med 2001; 28:64-71.